Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This study is a prospective single-center clinical study, which aims to observe and evaluate
the efficacy and safety of apatinib combined with temozolomide and oral etoposide in the
treatment of recurrent medulloblastoma in children.